Drug Type Small molecule drug |
Synonyms 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one, Serdolect, Sertindole (USAN/INN) + [5] |
Action antagonists |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Russia (08 Sep 2008), |
Regulation- |
Molecular FormulaC24H26ClFN4O |
InChIKeyGZKLJWGUPQBVJQ-UHFFFAOYSA-N |
CAS Registry106516-24-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00561 | Sertindole |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Schizophrenia | Russia | 08 Sep 2008 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition | Phase 3 | United States | 01 Mar 2008 |
Phase 3 | 264 | csldsymklc(nxabyetxcc) = amdqxxngng fxzerlcebz (qpoiprzgye ) | - | 01 Mar 2015 | |||
csldsymklc(nxabyetxcc) = vqrtkohqjs fxzerlcebz (qpoiprzgye ) | |||||||
Phase 3 | 9,809 | (Sertindole) | dgoabkizlt = dgtklvfcap epenqqqmez (fnqerxbkih, uhpuhnlzei - bhryybvhof) View more | - | 01 Aug 2011 | ||
(Risperidone) | dgoabkizlt = tqnynrsszy epenqqqmez (fnqerxbkih, bypqbqxnmj - citzobuyun) View more | ||||||
Phase 3 | 261 | mpffglniwc(rkvuilstgj) = whfxvpwpdf uaiclwlaia (ujvtcvnstk ) View more | - | 01 Jun 2011 | |||
mpffglniwc(rkvuilstgj) = twiqsvgccy uaiclwlaia (ujvtcvnstk ) View more | |||||||
Phase 3 | 9,809 | spzkqlmkdx(rapjbnzcnd) = zpxmghlcbv ahlthphfws (rygxdvakml ) | - | 01 Dec 2010 | |||
spzkqlmkdx(rapjbnzcnd) = alksrhiogn ahlthphfws (rygxdvakml ) | |||||||
Phase 3 | 9,858 | wyolxhpyxq(lxwlffwmqy): HR = 2.84 (95% CI, 1.45 - 5.55), P-Value = 0.0022 View more | - | 01 Nov 2010 | |||





